The Delhi High Court has dropped all criminal charges against the Gautam Gambhir Foundation over alleged illegal stocking of COVID-19 medicines during the second wave. The court found no proof of black marketing or misuse of drugs distributed in public interest.
Today, On 30th January, The Supreme Court criticized the lower court’s decision to issue summons in a case against a company accused of making poor-quality drugs. The court dismissed the case, saying there was not enough evidence to support the claims. The company was accused of producing substandard medicines, but the Supreme Court found no proof. This ruling raises concerns about how such cases are handled legally.
Dabur has filed a lawsuit against Patanjali Ayurved in the Delhi High Court Tuesday (24th Dec),, alleging that Patanjali aired misleading advertisements claiming its Chyawanprash is the “original” product. Dabur seeks to restrain these ads, arguing they harm its business and mislead consumers. The case is scheduled for a hearing in January.
![[Patanjali Controversy] Delhi HC Petition Alleges Non-Veg Ingredients in 'Tooth Powder' Labeled as Vegetarian](https://i0.wp.com/lawchakra.in/wp-content/uploads/2024/08/image-90-3.png?resize=447%2C367&ssl=1)
Today, On 30th August, Baba Ramdev and Patanjali face legal challenges over Divya Dant Manjan tooth powder labeled as vegetarian, but allegedly containing non-vegetarian cuttlefish. The Delhi High Court issued notices, and the next hearing is on November 28. This adds to previous legal issues, including deceptive advertising and safety concerns. Patanjali has faced multiple legal challenges over the years.
The Delhi High Court dismissed a PIL petition asking for doctors to provide written information on medication side effects, stating that the duty to inform patients lies with drug manufacturers and pharmacists. The court rejected the argument that doctors should also provide this information, deeming the PIL unnecessary. The petitioner’s claim was not seen as disputing the adequacy of the existing framework.
The Supreme Court of India overturned a prison term for a doctor found with unlicensed drugs, instead imposing a Rs 1 lakh fine. The ruling emphasizes that possessing a small quantity of medicines without disclosing the source does not endanger public interest, particularly when intent to sell or distribute remains unproven. This significant judgment provides legal protection for healthcare professionals stocking medicines for patient care.
